Labcorp Holdings Inc. (LH) exhibits 28.8% gross margins and 8.3% return on invested capital within Health Care (Medical Specialities), balanced against a 19.6x enterprise multiple and 6.8% implied options volatility.
Sustained 28.8% gross profitability converts into 9.9% operating margin and 8.3% ROIC, outpacing sector cost of capital.
ROIC: 8.3% // GM: 28.8%YoY revenue trajectory of +7.2% paired with 4.04% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +7.2% // FCF YLD: 4.04%Altman Z-Score of 3.58 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.58 // F-SCORE: 8/9Trading at 34.0x trailing P/E (31.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 34.0x // EV/EBITDA: 19.6xOptions market prices a ±6.8% implied move with a 0.70 put/call ratio around $361.00 max pain.
IMPL MOVE: ±6.8% // P/C: 0.70Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend 6.3% net margins.
NET MARGIN: 6.3% // D/E: 0.59x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for LH & activate live FRED threshold breach alerts.